News, Features and Opinion EditorSolicitors Journal

CMA gives provisional green light to healthcare tech deal

CMA gives provisional green light to healthcare tech deal

An investigation by the Competition and Markets Authority found no issues with UnitedHealth’s proposed £1.2bn purchase of EMIS.

The Competition and Markets Authority announced its decision on 11 August. In a press release it said:

The NHS is increasingly seeking digital and data-driven solutions to help improve the delivery of healthcare in the UK. EMIS supplies data management systems to the NHS, including the electronic patient record system used by the majority of NHS GPs in the UK. Optum, part of the US healthcare giant UnitedHealth, currently supplies software used by GPs when prescribing medicines, as well as data analytics and advisory services that the NHS uses to help improve overall healthcare and health service provision.

While the merging businesses do not supply competing services, Optum and its competitors use the data that EMIS holds and integrate their own software with EMIS’s electronic patient record system to compete in other markets, including the supply of population health management services and medicines optimisation software.

A CMA Phase 1 investigation had identified initial concerns that the merger ran the risk of worse outcomes for the NHS by reducing competition. These concerns have been probed in more detail in a Phase 2 investigation overseen by an independent panel which has now provisionally found the merger does not raise competition concerns.

The investigation confirmed that EMIS, as the lead supplier to NHS GPs across the UK, holds a particularly strong market position in the supply of electronic patient record systems but, further evidence-gathering and analysis found the combination of this position with Optum’s activities should not present competition concerns.

In the supply of population health management services, the independent panel provisionally found that the merged business would not, in practice, be able to use the EMIS business to harm the competitiveness of rivals. This is primarily because the NHS would be able to use its oversight role to prevent the merged business from pursuing this kind of strategy.

In relation to the supply of medicines optimisation software, the independent panel has provisionally found that it would not be commercially beneficial for the merged business to restrict access to EMIS’s electronic patient record system. In particular, a more detailed analysis of the market shows that such a strategy would likely be unprofitable with any possible gains being limited and capable of being reduced through intervention by the NHS.

The CMA's findings are provisional and the agency will now consult on its findings and listen to any further views before reaching a final decision.

AdvertisementAdvertisementAdvertisementAdvertisementAdvertisementAdvertisement
Latest News

Axiom Ince collapses: Police investigation begins

Tue Oct 03 2023

Barrister Carly Walters ordered to be disbarred

Tue Oct 03 2023

Fines to increase for employers without robust employment screening

Mon Oct 02 2023

IBA publishes for the first time a legal agenda identifying profession’s most pressing concerns

Mon Oct 02 2023

Black History Month: Legal profession celebrates influential Black women lawyers

Mon Oct 02 2023

The Law Society intervention ensures liberal approach to dealing with concurrent problems on legal aid

Fri Sep 29 2023

Jeanne Kelly elected President of the British Irish Chamber of Commerce

Fri Sep 29 2023

Families continue to be victims of a broken justice system

Fri Sep 29 2023

Call for compensation scheme extension to help more abuse survivors

Fri Sep 29 2023
FeaturedChris Packham legal action over Rishi Sunak's announcement
Chris Packham legal action over Rishi Sunak's announcement
Why civil mediation is the smarter choice than pressing for your day in court
Why civil mediation is the smarter choice than pressing for your day in court
SRA now managing the Solicitors Indemnity Fund
SRA now managing the Solicitors Indemnity Fund
Law Society concerned over fixed recoverable costs rollout
Law Society concerned over fixed recoverable costs rollout
SJ Interview: Hannah Ambrose
SJ Interview: Hannah Ambrose
Whose human rights are more important, yours or mine?
Whose human rights are more important, yours or mine?